SUVEN LIFE SCIENCES LTD (SUVEN) financials — quarterly results, P&L, cash flow, balance sheet, shareholding
Suven Life Sciences Ltd is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialisation of novel therapeutics for the treatment of neurodegenerative disorders.[1]
Suven Life Sciences Ltd
SUVEN
Market Cap₹8,846Cr.
Current Price₹313
High / Low₹371/124
Stock P/E
Book Value₹57.0
Dividend Yield0.00%
ROCE-4.72%
ROE-4.76%
Face Value₹1.00
Suven Life Sciences Ltd is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialisation of novel therapeutics for the treatment of neurodegenerative disorders.[1]
Quarterly Results
Yearly Results
Shareholding Pattern
Shareholding Trend
Balance Sheet
Cash Flows
Last updated at: 24 July 2026 at 10:08:02